Oxytocin nasal spray for challenging behaviors in autism
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether adding oxytocin nasal spray to standard behavioral therapy can help reduce challenging behaviors in children with autism and intellectual disability. It aims to see if the treatment is safe and practical.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child has a diagnosis of autism spectrum disorder (severe intensity) and moderate to severe intellectual disability
- Child has challenging behaviors, such as aggression or self-injury, confirmed by a doctor
- Child is already receiving multi-professional educational and behavioral therapy
- If child takes psychiatric medications, doses have been stable for at least 3 months
- Parents must be able to understand French and sign a consent form
- Child must not have certain heart, kidney, or liver problems, epilepsy, diabetes, or allergies to the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This trial tests whether a nose spray given before anesthesia can help children with autism feel calmer and have fewer behavior problems after surgery. It compares two medications, dexmedetomidine and esketamine, to see if they reduce negative post-surgery changes.
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study aims to measure how well different treatments work for young children with autism and intellectual disability who have challenging behaviors like aggression or self-injury. It may help you and your child find a treatment that reduces these behaviors and improves daily life.
This study tests whether the drug MDMA (commonly known as ecstasy) affects levels of oxytocin (a hormone linked to social bonding) in adults with mild autism compared to healthy volunteers. The goal is to see if MDMA might help with social challenges, but it's an early research study and not a treatment for autism.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.